GEMTUZUMAB OZOGAMICIN

3665 reported adverse events

Drug classes: CD33-directed Immunoconjugate [EPC]

These side effects are most commonly reported by patients taking GEMTUZUMAB OZOGAMICIN:

# Side effect Count
0 FEBRILE NEUTROPENIA 698
1 PYREXIA 326
2 SEPSIS 302
3 VENOOCCLUSIVE LIVER DISEASE 260
4 THROMBOCYTOPENIA 240
5 PLATELET COUNT DECREASED 236
6 PNEUMONIA 197
7 NEUTROPENIA 194
8 WHITE BLOOD CELL COUNT DECREASED 185
9 ASPARTATE AMINOTRANSFERASE INCREASED 184
See all common reactions for GEMTUZUMAB OZOGAMICIN

GEMTUZUMAB OZOGAMICIN is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 VENOOCCLUSIVE LIVER DISEASE 260 0.0526
1 VENOOCCLUSIVE DISEASE 109 0.0435
2 FEBRILE NEUTROPENIA 698 0.0105
3 ACUTE MYELOID LEUKAEMIA 151 0.0097
4 BRONCHOPULMONARY ASPERGILLOSIS 55 0.0071
5 DISSEMINATED INTRAVASCULAR COAGULATION 77 0.0055
6 BONE MARROW FAILURE 109 0.0054
7 BLOOD BILIRUBIN INCREASED 138 0.0051
8 MULTI-ORGAN FAILURE 84 0.0049
9 BACTERAEMIA 52 0.0044
See all enriched reactions for GEMTUZUMAB OZOGAMICIN